By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported first-quarter revenue growth of one percent, as it cut its net loss sharply on lower costs.

The Hopkinton, Mass.-based firm reported total revenues of $28.7 million for the three-month period ended March 31, compared to $28.5 million for the first quarter of 2009. Though its revenues were up only one percent, excluding the effect of divested non-core operations over the past year, Caliper's revenues were up 13 percent year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.